Related Articles Even Market-Neutral Funds Couldn’t Escape the AI Slump in October It’s Biopharma or Bust for the IPO Market Stephen Taub Fireside Chat- Private Credit's Next Chapter: Differentiation, Discipline, and Opportunity Sponsored by Principal Asset Management